
Pharmaceutical
Novartis Invests $23 Billion to Make Medicines in U.S.
In a bold move signaling its deepening commitment to the U.S. market, Swiss pharmaceutical giant Novartis announced plans to invest $23 billion over the next five years to dramatically expand its American footprint. The investment includes the construction of six new manufacturing facilities, expansion of three existing ones, and